白细胞介素-25轴参与人原发性干燥综合征及实验性小鼠干燥综合征的发病机制
研究探讨白细胞介素-25(IL-25)/IL-17受体B(IL-17RB)轴在实验性干燥综合征(SS)及原发性SS和原发性SS相关淋巴瘤患者中的作用。结果显示IL-25/IL-17RB/TRAF6轴活化与灶性评分相关,炎性ILC2频率显著增加,IL-25刺激可致炎性ILC2扩增和自身抗体产生增加,利妥昔单抗可调节炎性ILC2和IL-25表达,IL-25中和可减轻小鼠疾病进展。结论认为IL-25可能促进原发性SS炎症状态,并可能成为新型疾病修饰治疗策略的潜在靶点。
要点
- IL-25/IL-17RB/TRAF6轴活化与原发性SS患者灶性评分相关,并在原发性SS相关淋巴瘤中观察到。
- 原发性SS患者唾液腺单核细胞和外周血单核细胞中炎性ILC2频率显著增加。
- IL-25中和可减轻实验性SS小鼠的疾病进展和组织病理。
核心结论
- IL-25可能促进原发性SS的炎症状态,并可能成为原发性SS患者新型疾病修饰治疗策略的潜在靶点。
研究设计与样本
- 分析原发性SS患者小唾液腺样本及原发性SS相关B细胞非霍奇金淋巴瘤患者腮腺样本中IL-25、IL-17RB、IL-17B和TRAF6的表达。
- 通过流式细胞术评估唾液腺单核细胞和外周血单核细胞中IL-17RB表达及自然ILC2、炎性ILC2和M2极化巨噬细胞频率。
- 通过共聚焦显微镜研究ILC2的组织分布,体外研究重组IL-25和利妥昔单抗对IL-25表达的调节。
- 在实验性SS小鼠模型中研究IL-25/IL-17RB和TRAF6表达及IL-25抑制的作用。
主要发现
- IL-25/IL-17RB/TRAF6轴活化与灶性评分相关,并在原发性SS患者和原发性SS相关非霍奇金淋巴瘤患者中观察到。
- 唾液腺单核细胞和外周血单核细胞中炎性ILC2频率均显著增加。
- IL-25刺激患者和对照的分离唾液腺单核细胞及外周血单核细胞均导致炎性ILC2扩增和自身抗体产生增加。
- 利妥昔单抗调节原发性SS中炎性ILC2和IL-25的表达。
- 唾液腺蛋白免疫小鼠出现明显SS症状,IL-25表达增加,CD4+IL-17RB+TRAF6+细胞频率增加;IL-25中和减轻实验性SS小鼠的疾病进展和组织病理。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the role of the interleukin-25 (IL-25)/IL-17 receptor B (IL-17RB) axis in experimental Sjögren's syndrome (SS) and in patients with primary SS and primary SS-associated lymphoma. METHODS: Expression of IL-25, IL-17RB, IL-17B, and tumor necrosis factor receptor-associated factor 6 (TRAF6) was analyzed on minor salivary gland (SG) samples from patients with primary SS and on parotid gland samples from patients with primary SS-associated B cell non-Hodgkin's lymphoma (NHL). IL-17RB expression and the frequencies of natural group 2 innate lymphoid cells (ILC2s), inflammatory ILC2s, and M2-polarized macrophages were assessed by flow cytometry in SG mononuclear cells and peripheral blood mononuclear cells (PBMCs). Tissue distribution of ILC2s was studied by confocal microscopy. The role of recombinant IL-25 and of rituximab in modulating IL-25 expression was investigated in in vitro studies. IL-25/IL-17RB and TRAF6 expression and the role of IL-25 inhibition were also studied in the experimental murine model of SS. RESULTS: Activation of the IL-25/IL-17RB/TRAF6 axis correlated with the focus score and was observed in patients with primary SS and in patients with primary SS-associated NHL. A significant increase in the frequency of inflammatory ILC2s was observed both in SG mononuclear cells and in PBMCs. IL-25 stimulation of isolated SG mononuclear cells and PBMCs from patients and controls resulted both in inflammatory ILC2 expansion and in increased autoantibody production. Rituximab modulated expression of inflammatory ILC2s and IL-25 in primary SS. SG protein-immunized mice developed overt SS symptoms with increased IL-25 expression and increased frequency of CD4+IL-17RB+TRAF6+ cells. IL-25 neutralization attenuated disease progression and tissue pathology in mice with experimental SS. CONCLUSION: IL-25 may promote the inflammatory state in primary SS and may be a potential target for novel disease-modifying therapeutic strategies in patients with primary SS.
引用
- Guggino G, Lin X, Rizzo A, et al. Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome. Arthritis Rheumatol. 2018. PMID: 29569854. doi:10.1002/art.40500
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。